Patients Will Not Benefit From Select Committee Recommendations On NICE, Says ABPI, UK

Patients will see little benefit in their access to modern, innovative medicines if the recommendations of the House of Commons Health Select Committee are put into effect, the Association of the British Pharmaceutical Industry (ABPI) said.For the first time, a formal report has acknowledged that the National Institute for Health and Clinical Excellence (NICE) is a body set up to enforce the rationing of medicines.

More: continued here

Filed under: Pharma Industry on January 12th, 2008